ArticleJournal of gastrointestinal oncology2016
Management of high-output chylous ascites after D2-lymphadenectomy in patients with gastric cancer: a multi-center study.
Article in Journal of gastrointestinal oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies.World journal of surgical oncology · 2017Pooled it
- Successful management of refractory chylous ascites using a Denver shunt following conversion surgery for unresectable locally advanced pancreatic cancer.Clinical journal of gastroenterology · 2026Article
- Long-term conservative treatment of chylous ascites in gynecological malignant surgery: a case report and literature review.International cancer conference journal · 2025Article
- Chylous Ascites After Gastric Cancer Surgery: Risk Factors and Treatment Results.Journal of gastric cancer · 2023Article
- Novel management indications for conservative treatment of chylous ascites after gastric cancer surgery.World journal of gastroenterology · 2022Article
- Postoperative chylous ascites after total gastrectomy successfully treated using peritoneovenous (Denver) shunt: a case report.Surgical case reports · 2022Article
- Management of chylous ascites following pancreaticobiliary surgery.JGH open : an open access journal of gastroenterology and hepatology · 2019Article
- Management of postoperative complications of lymphadenectomy.Translational gastroenterology and hepatology · 2016Review
- Successful Conversion Surgery Following Chylous Ascites After Nivolumab for Advanced Gastric Cancer.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to propose treatment strategies for high-output chylous ascites (CA) developed after gastric cancer surgery.
methodsThe data of patients with CA after gastric cancer surgery in three high volume Training and Research Hospitals between 2005 and 2015 were retrospectively evaluated.
resultsNine patients out of 436 gastrectomies were detected with CA. The mean amount of daily fistula output was 939 mL. Treatment consisted of cessation of oral feeding, total parenteral nutrition (TPN), somatostatin analogs administration, clamping and/or removal of the drainage tube, diuretic administration and diet therapy with medium-chain triglycerides (MCTs) alone or in combination. The mean fistula closure time and length of hospital stay were 23 and 24 days respectively. Hemopneumothorax developed during right subclavian vein catheterisation for TPN implementation in one patient. There was no mortality.
conclusionsCombined cessation of oral feeding and TPN are usually used for treatment of CA as first-line treatment. However, TPN is no harmless. Although our data are limited they do allow us to conclude that diet with MCT's may use for medical treatment of CA as first-line.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.